Skip to content

Dossier · CAL · Dormant

CAL · Caleres Inc · Stock research

Last analysed ·

Current thesis

Q1 re-rate is spent and the tape has gone flat — CAL has chopped a tight $11–$12.6 band near $11.78 (2026-07-24), ~19% below its pre-print level and under the lost low-$13s June shelf. Slow brand-mix-shift value name, not an accelerating narrative; the only asymmetric kicker is a ~$57.8M IEEPA tariff refund excluded from guidance. A pass at current price.

Invalidation trigger

A weekly close below $10.50 loses the post-earnings recovery base off the $8.80 52-week low and confirms the value-trap read; secondary confirmation from Famous Footwear Q2 comps worse than the guided down mid-single-digit, or a punitive July 2026 tariff enactment on its China/Vietnam sourcing.

Thesis status

Open commitment catalyst 73d agoscored if the trigger above fires How this is scored →

Latest analysis and events for CAL —

As of 2026-07-26, orbyd's latest analysis for Caleres Inc (CAL): Q1 re-rate is spent and the tape has gone flat — CAL has chopped a tight $11–$12.6 band near $11.78 (2026-07-24), ~19% below its pre-print level and under the lost low-$13s June shelf. Slow brand-mix-shift value name, not an accelerating narrative; the only asymmetric kicker is a ~$57.8M IEEPA tariff refund excluded from guidance. A pass at current price.

Invalidation trigger: A weekly close below $10.50 loses the post-earnings recovery base off the $8.80 52-week low and confirms the value-trap read; secondary confirmation from Famous Footwear Q2 comps worse than the guided down mid-single-digit, or a punitive July 2026 tariff enactment on its China/Vietnam sourcing.

Most recent dated event on file: — catalyst 73d ago.

Current Thesis

Two-speed footwear operator whose Q1 re-rate is spent and whose tape has gone quiet. A premiumizing Brand Portfolio (Sam Edelman, Allen Edmonds, Stuart Weitzman, Naturalizer, Vionic) is lifting margin while Famous Footwear keeps shrinking. There is no momentum leg — a slow mix-shift value name re-rated lower, with one asymmetric kicker: a ~$57.8M IEEPA tariff refund excluded from guidance, ~15% of a $395.7M cap. Cheap on forward numbers (~7.7x) but two-sided into the July tariff enactment. Low-conviction; the setup is a pass at current price.

Bullish and bearish views on Caleres Inc

The model's bull view on Caleres Inc (CAL), in brief: Brand Portfolio Q1 sales +20.6% (organic +5.8% ex-Stuart Weitzman), segment gross margin 49% (+520 bps YoY); Allen Edmonds grew ~20% and Sam Edelman posted double-digit domestic and international growth (Q1 call 2026-06-04). The bear view: Famous Footwear Q1 comps -2.3%, segment sales -2.5%, gross margin -150 bps on higher markdowns and shipping; Q2 explicitly guided to stay down mid-single-digits (2026-06-04). Both cases follow in full.

Bull Case

  • Brand Portfolio Q1 sales +20.6% (organic +5.8% ex-Stuart Weitzman), segment gross margin 49% (+520 bps YoY); Allen Edmonds grew ~20% and Sam Edelman posted double-digit domestic and international growth (Q1 call 2026-06-04).
  • ~$57.8M plus interest in invalidated-IEEPA refund eligibility flagged 2026-06-04, booked only on collection and excluded from guidance — ~15% of the $395.7M cap sitting off-balance-sheet as binary upside; a collection headline is the cleanest surprise.
  • Consolidated gross margin 47.3% in Q1, +200 bps YoY, as the mix shifts toward Brand Portfolio even while Famous Footwear softens.
  • FY2026 adjusted EPS guide raised to $1.40–$1.65 (from $1.35–$1.65) on 2026-06-04; midpoint ~$1.525 implies ~7.7x on the $11.78 (2026-07-24) close.
  • Dislocated small-cap: ~2.4% dividend yield ($0.28), a Buy-tilted consensus (~77% buy), and average targets in the ~$15–$17 zone versus $11.78 — the profile that snaps back on any sentiment reversal.

Bear Case

  • Famous Footwear Q1 comps -2.3%, segment sales -2.5%, gross margin -150 bps on higher markdowns and shipping; Q2 explicitly guided to stay down mid-single-digits (2026-06-04). This is the larger revenue base, in secular decline against a soft low-income consumer.
  • The beat was pre-paid: +14% run-in, +0.64% on 2026-06-04, then a ~19% bleed. The low-$13s June shelf is gone and three weeks of flat $11–$12.6 tape show no bid returning.
  • The raise is thin and still trails the Street: FY midpoint ~$1.525 sits below ~$1.56 consensus, and the group's average target has eased ~12% over three months.
  • The +20.6% brand headline is flattered by the Stuart Weitzman acquisition; organic growth was only +5.8%.
  • Tariff regime is unhedged and two-sided: FY guidance assumes new tariffs land ~July 2026 to replace prior IEEPA duties. With sourcing concentrated in China and Vietnam, a punitive July headline is a gap risk landing this month.

Setup & Price Structure

$11.78 close on 2026-07-24 (+0.86% on the day), market cap $395.7M. The three-week range is roughly $11.0–$12.6; a mid-July poke toward ~$12.5 faded straight back. The stock lost its low-$13s pre-earnings shelf on the post-print drift and has not reclaimed it. Against the $8.80–$16.14 52-week range it sits in the lower third, ~27% off the high and ~34% above the low. Trailing GAAP P/E is optically distorted (~900x) by depressed, acquisition-charged TTM earnings, while the forward multiple is ~7.7x on the guide. This is dead tape, not a base build — no trend to lean on and nothing to chase. A reclaim of the $13s on expanding volume would be the first sign of life.

Catalyst Calendar (next 30 days)

  • ~July 2026 (ongoing): new tariff enactment expected to replace invalidated IEEPA duties — an undated, two-sided gap risk that is live this month.
  • IEEPA refund collection (~$57.8M plus interest): no scheduled date; a collection or settlement headline could arrive at any time and is the single cleanest upside surprise, excluded from guidance.
  • No company earnings inside the window. The next print is Q2 FY2026, est. ~2026-09-04, which is outside 30 days — no earnings-blackout concern until late August.

What Would Change Our Mind

A bull re-rate needs the story to re-accelerate: a reclaim of the low-$13s shelf on expanding volume, a benign or favorable July tariff outcome, an IEEPA refund collection headline, or Famous Footwear comps turning less-bad than the guided down mid-single-digits. Bear confirmation runs the other way: a weekly close below $10.50 loses the post-earnings recovery base off the $8.80 52-week low and validates the value-trap read, with secondary confirmation from Famous Footwear Q2 comps worse than guided or a punitive July 2026 tariff enactment on China/Vietnam sourcing.

Correlation Notes

CAL moves with small-cap value and consumer-discretionary retail — read it against XRT and consumer-cyclical tape plus low-income spending data (jobs, real wages, mall traffic). It is tariff-headline-sensitive alongside other China/Vietnam-sourced softlines importers (SKX, SHOO, WWW, DECK on a beta basis), and peer footwear/apparel comps are direct read-throughs to Famous Footwear. The idiosyncratic swing factor is regulatory — the IEEPA refund and tariff policy — which can decouple the name from its group on headline days in either direction.

Notes

  • No live intraday price context beyond the 2026-07-24 close ($11.78); confirm a fresh quote before acting.
  • Earnings blackout: avoid fresh entries in the 3 trading days before the Q2 FY2026 print, est. ~2026-09-04. No blackout concern until late August.
  • Not a momentum name — do not size above LOW. If it ever squeezes it will show on unusual-options + retail-velocity, not on this slow brand-pivot story.
  • Structure: Caleres = Famous Footwear (declining family footwear chain) + Brand Portfolio (Sam Edelman, Allen Edmonds, Stuart Weitzman, Naturalizer, Vionic, Dr. Scholl's, Franco Sarto). Brand Portfolio is the only part with narrative optionality.
  • Tariff/sourcing exposure (China/Vietnam) is the real bear risk and an instant gap risk on any headline.
  • ~$57.8M IEEPA refund is excluded from guidance and booked only on collection — cleanest upside surprise, ~15% of the ~$396M cap.
  • Q1 FY2026 catalyst has passed (reported 2026-06-04): beat, soft guide, +0.64% reaction after a +14% run-in. Not a fresh catalyst setup.
  • Q1 Brand Portfolio +20.6% is flattered by the Stuart Weitzman acquisition; organic was +5.8%.

Related · shared themes

See also · stocks to watch